Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Processing-independent proANP measurement for low concentrations in plasma: reference intervals and effect of body mass index and plasma glucose

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Development and validation of a mass spectrometry-based assay for quantification of insulin-like factor 3 in human serum

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Gender-partitioned patient medians of serum albumin requested by general practitioners for the assessment of analytical stability

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Individual values of antineutrophil cytoplasmic antibodies do not correspond between antigen-specific assays

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  4. Precision of nonfasting lipid profiles should focus on clinical relevance rather than necessarily obtaining the least variation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Transcriptome analysis in patients with temporal lobe epilepsy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. ProANP and proBNP in plasma as biomarkers of heart failure

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. In Reply

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  4. Diagnosing von Willebrand disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: Decreased concentrations of pro-atrial-derived natriuretic peptides (proABP) in plasma have been associated with obesity and suggested as a predictor of type 2 diabetes. However, assays for measuring proANP are generally aimed to quantitate higher concentrations of proANP associated with cardiac disease. Therefore, we aimed to measure plasma proANP concentrations in a non-obese Scandinavian reference material and evaluate potential associations of plasma proANP with body mass index (BMI) and plasma glucose, respectively.

METHODS: We report an optimized processing-independent assay (PIA) for proANP in the lower concentration range. The assay was optimized by raising the amount of radioactive tracer and modifying the mixing ratio of resuspended plasma and buffer. Blood samples from a Scandinavian plasma cohort of 693 healthy subjects were then analyzed and age and gender-specific reference intervals were determined.

RESULTS: Simple linear regression analyses of proANP and both BMI and plasma glucose in fasting subjects displayed insignificant associations. Multiple regression analyses supported these findings. However, a higher median plasma concentration of proANP was noted among women <50 years compared to men, whereas no gender-specific differences were seen in other age groups.

CONCLUSIONS: Our results show that in a healthy non-obese population, BMI and plasma glucose in fasting subjects do not affect plasma proANP concentrations. Our method should be considered for future studies on low proANP concentration studies, e.g. in obesity and diabetes.

OriginalsprogEngelsk
TidsskriftClinical Chemistry and Laboratory Medicine
Vol/bind56
Udgave nummer1
Sider (fra-til)132-137
Antal sider6
ISSN1434-6621
DOI
StatusUdgivet - 2018

ID: 52184043